&nbsp;

CRBPGEMC-FR.pdf

Sep 2020

Document

CRBPGEMC.pdf

Sep 2020

Comment le questionnaire Vos symptômes sont importants peut-il vous aider

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Regimen

CISPFU+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

, Collapse Show fewer tags

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

CRBPFU+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

, Collapse Show fewer tags

Drugs Used:

Quick Link(s):

Regimen Monograph

COVID-19 and Cancer Care: Your Safety Matters

Regimen

CEP+BREN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade,

Lymphoma - T-cell

Intent: Curative, Palliative

Funding:

ODB - General Benefit

prednisone

ODB - General Benefit

etoposide - oral capsules

New Drug Funding Program

Brentuximab Vedotin - In Combination with Chemotherapy for Previously Untreated Peripheral T-cell Lymphoma (PTCL)

, Collapse Show fewer tags

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2022

Drug

cemiplimab

Other Name(s): Libtayo™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Document

CoP_fall_2020_slides_final_Webinar 2_November_26_final.pdf

Dec 1969

Document

colposcopyCommunityOfPracticePart1.mp4

Dec 1969

Document